Taxanes are effective anti-cancer microtubule (MT) drugs, yet why they clinically outperform other spindle poisons is unclear. New work shows that taxanes, unlike other MT-stabilizing agents, force MT lattices into an expanded state that evicts GEF-H1, coupling MT pharmacology to Rho signalling and actin remodelling in interphase.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
Learn more
Subscribe to this journal
Receive 12 print issues and online access
Learn more
Rent or buy this article
Prices vary by article type
Learn more
Prices may be subject to local taxes which are calculated during checkout
References
Gallego-Jara, J., Lozano-Terol, G., Sola-Martinez, R. A., Canovas-Diaz, M. & de Diego Puente, T. Molecules 25, 5986
https://doi.org/10.3390/molecules25245986(2020).Horwitz, S. B. Cell 177, 502–505
https://doi.org/10.1016/j.cell.2019.03.031(2019).Jordan, M. A. & Wilson, L. Nat. Rev. Cancer 4, 253–265
https://doi.org/10.1038/nrc1317(2004).Tang, P. A. et al. Invest. New Drugs 26, 257–264
https://doi.org/10.1007/s10637-007-9098-8(2008...